A double blind, placebo-controlled randomized trial of low-dose risperidone, cognitive-behaviour therapy, and befriending in young people with subthreshold symptoms at incipient risk of psychotic disorder: six month outcome data
Version 2 2024-06-05, 11:36Version 2 2024-06-05, 11:36
Version 1 2021-05-12, 15:46Version 1 2021-05-12, 15:46
conference contribution
posted on 2024-06-05, 11:36authored byPD McGorry, LJ Phillips, B Nelson, S Leicester, K Baker, H Krstev, P Amminger, G Berger, I Di Bella, A Thampi, S Francey, Alison YungAlison Yung
A double blind, placebo-controlled randomized trial of low-dose risperidone, cognitive-behaviour therapy, and befriending in young people with subthreshold symptoms at incipient risk of psychotic disorder: six month outcome data